Study points way to possible new treatment for ligament injuries

November 03, 2020

Durham, NC -Each year ligament injuries sideline thousands of athletes and regular citizens. Recovery is long and painful, and sometimes a return to full function is never realized due to scar formation - a factor that makes ligament injuries prone to further damage. A new exosomes study released today in STEM CELLS may lead to a welcomed solution in the future.

This study demonstrates how exosomes, sacs of cell membrane in the body that shuttle proteins and genetic information between cells, and exosome-educated macrophages (EEMs), a type of white blood cell that typically kills microorganisms and removes dead cells, but also could stimulate the action of other immune system cells, can promote ligament healing and reduce scarring.

Last year the team behind this study, researchers at the University of Wisconsin-Madison (UW-Madison), released another study (also published in STEM CELLS) that showed how treating an Achilles tendon with EEMs reduces inflammation and improves tendon strength. The EEMs were generated by exposing CD14+ macrophages to mesenchymal stromal cell (MSC) derived exosomes.

"Our previous study was done on a mouse model," said Ray Vanderby, Ph.D., professor of orthopedics and rehabilitation at UW-Madison. He and Peiman Hematti, M.D., from UW-Madison's Department of Medicine, are corresponding authors on both of these studies. "While the results were superior when compared to treatment with MSCs, the functional/mechanical benefit of the exosomes was not as obvious as with the EEMs. This led us to our current study goals."

First, the researchers wanted to reproduce the healing effects of EEMs in a different rodent model - a rat medial collateral ligament (MCL), which is a ligament that runs along the edge of the knee. "We hypothesized the EEM treatment would reduce inflammation and accelerate ligament healing, similar to our previous tendon results," Dr. Vanderby said.

Secondly, they wanted to study the effects of exosome therapy on the rats' MCL injuries, hypothesizing that MSC-derived exosomes could also improve ligament healing and reduce scar formation.

When the results came in, they supported the team's speculation that EEMs did, indeed, improve rat MCL function and reduced the M1/M2 macrophage ratio, too. (M1 macrophages protect against bacteria and viruses, while M2 macrophages focus on wound healing and tissue repair.)

The exosomes also elicited a biological response - most notably, an increase in collagen and a reduction in scarring. "The ability of exosomes to reduce scar formation and upregulate collagen type expression has been documented in tendon healing models, but to our knowledge this is the first study to report this in ligaments," Dr. Vanderby said.

"This study is an exciting advance in the field of MSC-derived exosomes," said Dr. Jan Nolta, Editor-in-Chief of STEM CELLS "the demonstration by this excellent group that exosome-educated macrophages can play such a major role in both tendon and ligament healing has exciting potential for improving the trajectory of healing of human athletic injuries."

The investigators now question whether, in addition to promoting healing in ligament- and tendon-related injuries, EEMs and exosomes might be applied to other scarring debilities. Of special interest to this group is how they might be used to treat a wide range of degenerative and sport-related orthopedic conditions. However, EEMs and exosome could be investigated in a wide range of other applications, too, such as radiation damage to the bone marrow, another area of special interest to Dr. Hematti, as a bone marrow transplant physician.

"EEMs and exosomes each have attractive characteristics as therapeutics," Dr. Hematti noted. "As a cell therapy, EEMs will not proliferate or differentiate to undesirable cell types, which remains a concern for many stem cell therapies. Moreover, EEMs could be generated from a patient's own monocytes using off-the-shelf exosomes, resulting in a faster and more facile process compared to autologous MSCs. Alternatively, exosome therapy could be a cell free, shelf-stable therapeutic to deliver biologically active components."

"Altogether, we believe our studies' results support the use of EEMs and/or exosomes to improve ligament healing by modulating inflammation and tissue remodeling," Dr. Vanderby concluded.
-end-
The full article, "Exosome-educated macrophages and exosomes differentially improve ligament healing," can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/stem.3291.

About the Journal:STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS® is the world's first journal devoted to this fast paced field of research. THE ONCOLOGIST® is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE® is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

AlphaMed Press

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.